Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tonbo Biosciences
San Diego, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Tonbo Biosciences produced high-quality research antibodies and flow cytometry reagents extensively used for immune cell profiling in oncology, infectious disease, and immunology. Its reagents business was acquired by Cytek Biosciences in Q1 2022, and Tonbo’s catalog and technology are now part of Cytek’s offering
- Therapeutic areas
- OncologyInfectious DiseasesImmunology
- Modalities
- AntibodyReagentProtein
- Industry
- Non-Drug Biotech
02
Partnerships
Cytek Biosciences
Beyond the preview
Go deeper on Tonbo Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tonbo Biosciences.